B Barroso Selected Research

B Barroso Research Topics

2	Asthma (Bronchial Asthma) 04/2022 - 01/2022
2	Nasal Polyps (Nasal Polyp) 04/2022 - 01/2022
2	Rhinosinusitis 04/2022 - 01/2022
2	Hypertension (High Blood Pressure) 01/2022 - 12/2004
2	Mental Disorders (Mental Disorder) 01/2022 - 04/2001
1	Anosmia 04/2022
1	Polyps 04/2022
1	Bronchiectasis 01/2022
1	COVID-19 01/2022
1	Eosinophilia 01/2022
1	Type 2 Diabetes Mellitus (MODY) 11/2011
1	Deafness (Deaf Mutism) 11/2011
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2006
1	Multiple Sclerosis 05/2006
1	Stroke (Strokes) 05/2006
1	Seizures (Absence Seizure) 12/2004
1	Headache (Headaches) 12/2004
1	Acute Kidney Injury (Acute Renal Failure) 12/2004
1	Parkinsonian Disorders (Parkinsonism) 07/2002
1	Meningoencephalitis 12/2001
1	Hepatolenticular Degeneration (Wilson's Disease) 04/2001

2	Biological ProductsIBA 04/2022 - 12/2001
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 01/2022
1	reslizumabIBA 04/2022
1	benralizumabIBA 04/2022
1	Omalizumab (Xolair)FDA Link 04/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022
1	anti-IgE antibodiesIBA 04/2022
1	Pharmaceutical PreparationsIBA 04/2022
1	mepolizumabIBA 04/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	Bronchodilator Agents (Bronchodilators)IBA 01/2022
1	ferric oxide (iron oxide)IBA 05/2006
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 05/2006
1	Contrast MediaIBA 05/2006
1	GadoliniumIBA 05/2006
1	Bromocriptine (Parlodel)FDA LinkGeneric 12/2004
1	Valproic Acid (Depakote)FDA LinkGeneric 07/2002
1	Clozapine (Clozaril)FDA LinkGeneric 04/2001

1	Hearing Aids (Hearing Aid) 11/2011